교수
> 교수진 > 교수이익재
겸직교수/의학박사
- 전공분야 : 유방암, 간암, 췌담도암, 전립선암, 두경부암, 전이암, 영상유도방사선치료, 정밀방사선치료
- 이메일 : ikjae412@yuhs.ac
- 위치 : 광혜관
- 연락처 : 82-2-2228-8117
연구분야
영상유도방사선치료, 정밀방사선치료
방사선생물학, 신약개발
의료기기
방사선생물학, 신약개발
의료기기
소속 및 경력
[주요경력]
2005.5. ~ 2007.2 연세대학교 세브란스병원 강사
2007.3. ~ 2008.2 연세대학교 세브란스병원 전임강사
2008.3. ~ 2009.2 연세대학교 강남세브란스병원 전임강사
2009.2. ~ 2013.2 연세대학교 강남세브란스병원 조교수
2013.3. ~ 2015.2 미국 스탠포드대학교 의과대학 방사선종양학과 방문교수
2013.3. ~ 2018.2 연세대학교 강남세브란스병원 부교수
2018.3. ~ 2021.2 연세대학교 강남세브란스병원 교수
2015.3. ~ 2021.2 연세대학교 강남세브란스병원 방사선종양학과 과장
2021.3 ~ 현재 연세대학교 의과대학 방사선종양학교실 주임교수
2021.3 ~ 현재 연세암병원 방사선종양학과 과장
[기타경력]
대한방사선종양학회 국제협력이사
대한암학회 회원
대한간학회 회원
미국방사선종양학회(ASTRO) 회원
유럽방사선종양학회(ESTRO)회원
대한간암학회 회원
2005.5. ~ 2007.2 연세대학교 세브란스병원 강사
2007.3. ~ 2008.2 연세대학교 세브란스병원 전임강사
2008.3. ~ 2009.2 연세대학교 강남세브란스병원 전임강사
2009.2. ~ 2013.2 연세대학교 강남세브란스병원 조교수
2013.3. ~ 2015.2 미국 스탠포드대학교 의과대학 방사선종양학과 방문교수
2013.3. ~ 2018.2 연세대학교 강남세브란스병원 부교수
2018.3. ~ 2021.2 연세대학교 강남세브란스병원 교수
2015.3. ~ 2021.2 연세대학교 강남세브란스병원 방사선종양학과 과장
2021.3 ~ 현재 연세대학교 의과대학 방사선종양학교실 주임교수
2021.3 ~ 현재 연세암병원 방사선종양학과 과장
[기타경력]
대한방사선종양학회 국제협력이사
대한암학회 회원
대한간학회 회원
미국방사선종양학회(ASTRO) 회원
유럽방사선종양학회(ESTRO)회원
대한간암학회 회원
학력사항
연세대 의학과 졸업(1997)
연세대 대학원 의학과 석사
(2001)연세대 대학원 의학과 박사(2011)
연세대 대학원 의학과 석사
(2001)연세대 대학원 의학과 박사(2011)
교육 및 연구경력
[강의]
방사선생물학
방사선생물학
기타 학술 경력
[논문]
• Seong J, Lee IJ, Shim SJ, et al. A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea. Liver Int 2009;29:147-152.
• Lee IJ, Seong J, Shim SJ, et al. Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. Int J Radiat Oncol Biol Phys 2009;73:154-158.
• Song T, Suh CO, Lee I, et al. The effect of respiratory motion on forward intensity modulated radiotherapy for breast cancer. Technol Cancer Res Treat 2008;7:207-215.
• Lee IJ, Seong J, Lee CG, et al. Early Clinical Experience and Outcome of Helical Tomotherapy for Multiple Metastatic Lesions. Int J Radiat Oncol Biol Phys 2008 (Article in press).
• 유세환, 성진실, 이익재, et al. 간종양 방사선치료 시 토모테라피 메가볼트 CT를 이용한 치료 여백 평가. 대한방사선종양학회지 2008;26:280-288.
• 안승권, 김용배, 이익재, et al. 사지에 발병한 카포시육종의 방사선치료를 위한 물볼루스 기구의 유용성 고찰. 대한방사선종양학회지 2008;26:189-194.
• Shim SJ, Seong J, Lee IJ, et al. Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma. Hepatol Res 2007;37:906-913.
• Seong J, Shim SJ, Lee IJ, et al. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1037-1042.
• 김주영, 이익재, 금기창, et al. Internal Mammary Lymph Node Irradiation after Breast Conservation Surgery: Radiation Pneumonitis versus Dose-Volume Histogram Parameters. 대한방사선종양학회지 2007;25:261-267.
• 금기창, 심수정, 이익재, et al. 1998,1999년도 우리나라에서 시행된 근치적 유방 전절제술 후 방사선치료 현황 조사. 대한방사선종양학회지 2007;25:7-15.
• 이익재, 성진실, 심수정, et al. 간세포암종의 방사선치료 시 발생하는 간독성에 대한 위험인자의 재고찰. 대한간학회지 2006;12:420-428.
• 이익재, 성진실, 심수정, et al. 3차원입체조형방사선치료 계획 시 간종괴의 위치에 따른 최적 조사방향의 결정. 방사선방어학회지 2006;31:187-195.
• 조재호, 김현창, 서창옥, et al. 처방선량 및 치료기법별 치료성적 분석 결과에 기반한 자궁경부암 환자의 최적 방사선치료 스케줄. 대한방사선종양학회지 2005;23:143-156.
• Shin HS, Seong J, Kim WC, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys 2003;57:105-112.
• 이용하, 박경란, 이종영, et al. 측정기에 따른 고에너지 X-선의 표면 선량 및 최대 선량 지점 고찰. 대한방사선종양학회지 2003;21:322-329.
• Lee IJ, Park KR, Lee KK, et al. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2002;54:768-779.
• Results of definitive radiation therapy in adenosquamous cell carcinoma of the uterine cervix대한암학회지 33/1 :21-26,2001
• 병기 IB 자궁경부암에서 혈관내피세포성장인자(VEGF)의 발현이 예후에 미치는 영향대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 19/4 :335-344,2001
• Prognostic value of vascular endothelial growth factor in stage IB carcinoma of the uterine cervixINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 54/3 :768-779,2002
• 직장암의 근치적 절제술 후 보조 화학요법과 보조 화학방사선 병용요법대한방사선종양학회지(journalofthekoreansocietyfortherapeuticradiologyandoncology) 20/4 :334-342,2002
• Combination of external-beam irradiation and high-dose-rate brachytherapy for inoperable carcinoma of the extra-hepatic bile ductsINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 57/1 :105-112,2003
• Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ductsINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 57/1 :105-112,2003
• 측정기에 따른 고에너지 X-선의 표면 선량 및 최대 선량 지점 고찰대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 21/4 :322-329,2003
• 처방선량 및 치료기법별 치료성적 분석 결과에 기반한 자궁경부암 환자의 최적 방사선치료 스케쥴대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 23/3 :143-156,2005
• 담도암의 방사선치료대한췌담도연구회 1/ :72-79,2005
• 간세포암종의 방사선치료 시 발생하는 간독성에 대한 위험인자의 재고찰The Korean Journal of Hepatology(대한간학회지) 12/3 :420-428,2006
• 3차원입체조형방사선치료 계획 시 간종괴의 위치에 따른 최적 조사 방향의 결정대한방사선방어학회지 31/4 :187-195,2006
• Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 67/4 :1037-1042,2007
• Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinomaHEPATOLOGY RESEARCH 37/ :906-913,2007
• Internal Mammary Lymph Node Irradiation after Breast Conservation Surgery: Radiation Pneumonitis versus Dose-Volume Histogram Parameters대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 25/4 :261-267,2007
• 1998, 1999년도 우리나라에서 시행된 근치적 유방 전절제술 후 방사선치료 현황 조사대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 25/1 :7-15,2007
• The effect of respiratory motion on forward intensity modulated radiotherapy for breast cancerTechnology In Cancer Research & Treatment 7/ :207-215,2008
• 사지에 발병한 카포시육종의 방사선치료를 위한 물볼루스 기구의 유용성 고찰대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 26/3 :189-194,2008
• Treatment Margin Assessment using Mega-Voltage Computed Tomography of a Tomotherapy Unit in the Radiotherapy of a Liver Tumor대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 26/4 :280-288,2008
• A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in KoreaLiver International 29/ :147-152,2009
• RADIOTHERAPEUTIC PARAMETERS PREDICTIVE OF LIVER COMPLICATIONS INDUCED BY LIVER TUMOR RADIOTHERAPYINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73/1 :154-158,2009
• EARLY CLINICAL EXPERIENCE AND OUTCOME OF HELICAL TOMOTHERAPY FOR MULTIPLE METASTATIC LESIONSINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73/ :1517-1524,2009
• A Comparison of Treatment Plans using Linac-Based Intensity-Modulated Radiation Therapy and Helical Tomotherapy for Maxillary Sinus CarcinomaTechnology In Cancer Research & Treatment 8/4 :257-263,2009
• 비소세포성 폐암으로 수술 후 방사선치료가 시행된 N2병기 환자들에서 다발 부위 종격동 림프절 전이 여부에 따른 N2병기 구분의 임상적 의미Journal Of The Korean Society For Therapeutic Radiology And Oncology(대한방사선종양학회지) 27/3 :126-132,2009
• TUMOR HETEROGENEITY OF FIGO STAGE III CARCINOMA OF THE UTERINE CERVIXINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75/5 :1323-1328,2009
• Validation of Radiation Volume by Analysis of Recurrence Pattern in Breast-conserving Treatment for Early Breast CancerJournal Of Breast Cancer (한국유방암학회지) 12/4 :257-264,2009
• RISK FACTORS AND DOSE-EFFECT RELATIONSHIP FOR MANDIBULAR OSTEORADIONECROSIS IN ORAL AND OROPHARYNGEAL CANCER PATIENTSINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75/4 :1084-1091,2009
• 신경회로망을 이용한 4차원 방사선치료에서의 조사 표적 움직임 예측의학물리 20/3 :132-138,2009
• Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer RadiotherapyJournal Of Korean Medical Science 24/5 :894-903,2009
• A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean resultsLUNG CANCER 71/1 :55-59,2011
• Selection of the Optimal Radiotherapy Technique for Locally Advanced Hepatocellular CarcinomaJAPANESE JOURNAL OF CLINICAL ONCOLOGY 41/7 :882-889,2011
• Radiosensitizers in Hepatocellular CarcinomaSEMINARS IN RADIATION ONCOLOGY 21/4 :303-311,2011
• Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized StudyCancer Research and Treatment 43/1 :24-31,2011
• Radiotherapeutic Strategies in the Management of Hepatocellular CarcinomaONCOLOGY 81/Suppl :123-133,2011
• Helical tomotherapy for spine oligometastases from gastrointestinal malignancies대한방사선종양학회지 29/4 :219-227,2011
• Effect of Oral Supplementation with Branched-chain Amino Acid during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized StudyCancer Research and Treatment 43/1 :24-31,2011
• USEFULNESS OF POSITRON EMISSION TOMOGRAPHY WITH FLUORINE-18-FLUORODEOXYGLUCOSE IN PREDICTING TREATMENT RESPONSE IN UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH EXTERNAL BEAM RADIOTHERAPYINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 82/3 :1172-1178,2012
• Is There a Clinical Benefit to Adaptive Planning During Tomotherapy in Patients with Head and Neck Cancer at Risk for Xerostomia?AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 35/3 :261-266,2012
• The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinomaLIVER INTERNATIONAL 32/7 :1165-1171,2012
• The Optimal Selection of Radiotherapy Treatment for Hepatocellular CarcinomaGUT AND LIVER 6/2 :139-148,2012
• Molecular Markers Predict Distant Metastases After Adjuvant Chemoradiation for Rectal CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 84/5 :e577-e584,2012
• Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptorsCELLULAR IMMUNOLOGY 278/1-2 :76-83,2012
• Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 12-Year Follow-upINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 86/5 :867-872,2013
• Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular CarcinomaYONSEI MEDICAL JOURNAL 54/5 :1178-1185,2013
• A Comparative Planning Study of Step-and-shoot IMRT versus Helical Tomotherapy in a Model PatientJOURNAL OF THE KOREAN PHYSICAL SOCIETY 63/7 :1481-1485,2013
• Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinomaJOURNAL OF RADIATION RESEARCH 54/6 :1069-1077,2013
• The deep inspiration breath hold technique using Abches reduces cardiac dose in patients undergoing left-sided breast irradiationRadiation oncology journal 31/4 :217-224,2013
• High-dose Versus Standard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal CancerJAPANESE JOURNAL OF CLINICAL ONCOLOGY 44/6 :534-540,2014
• Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 140/9 :1595-1605,2014
• Dose escalation using helical tomotherapy improves local control in spine metastases fromprimary hepatic malignanciesLIVER INTERNATIONAL 34/3 :462-468,2014
• Inhibition of IL-17A Suppresses Enhanced-Tumor Growth in Low Dose Pre-Irradiated Tumor BedsPLOS ONE 9/Issue 9 :e106423-,2014
• Postoperative radiotherapy dose correlates with locoregional control in patients with locoregional control in patients with extra-hepatic bile duct cancerRadiation Oncology Journal 32/1 :7-13,2014
• Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular CarcinomaYONSEI MEDICAL JOURNAL 55/6 :1489-1497,2014
• Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiationDIGESTION 90/4 :254-260,2014
• Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patientsRadiation Oncology Journal 33/2 :75-82,2015
• A Feasibility Study of a Tilted Head Position in Helical Tomotherapy for Fractionated Stereotactic Radiotherapy of Intracranial MalignanciesTECHNOLOGY IN CANCER RESEARCH & TREATMENT 14/4 :475-482,2015
• Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental ratsRADIATION ONCOLOGY 10/1 :195-,2015
• Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching AnalysisCANCER RESEARCH AND TREATMENT 48/1 :190-197,2016
• Mechanical quality assurance using light field for linear accelerators with camera calibrationPHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS 32/ :398-402,2016
• Altered Biological Potential and Radioresponse of Murine Tumors in Different MicroenvironmentsCANCER RESEARCH AND TREATMENT 48/2 :727-737,2016
• Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 PatientsCANCER RESEARCH AND TREATMENT 48/2 :583-595,2016
• The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic GroupsPLOS ONE 11/4 :e0154739-,2016
• Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinomaONCOTARGET 7/26 :40756-40766,2016
• High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinomaONCOTARGET 7/33 :53921-53929,2016
• Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgeryJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/9 :1,619-1,627,2016
• Interobserver variability in gross tumor volume delineation for hepatocellular carcinomaSTRAHLENTHERAPIE UND ONKOLOGIE 192/ :714-721,2016
• Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy PerspectiveCANCER RESEARCH AND TREATMENT 49/1 :168-177,2017
• Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volumeRADIOTHERAPY AND ONCOLOGY 122/1 :24-29,2017
• Clinical application of 3D-printed-step-bolus in post-totalmastectomy electron conformal therapyONCOTARGET 8/15 :25,660-26,558,2017
• In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boostRadiation Oncology Journal 35/02 :121-128,2017
• Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective studyRADIATION ONCOLOGY 12/133 :1-8,2017
• Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in KoreaJOURNAL OF BREAST CANCER 20/3 :228-233,2017
• Maximum surgical resection and adjuvant intensity-modulated radiotherapy with simultaneous integrated boost for skull base chordomaACTA NEUROCHIRURGICA 159/ :1825-1834,2017
• Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancerSCIENTIFIC REPORTS 7/ :15732-,2017
• Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015Tuberculosis and Respiratory Diseases 81/1 :19-28,2018
• Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapyWORLD JOURNAL OF GASTROENTEROLOGY 24/7 :862-869,2018
• Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's PerspectiveCLINICAL BREAST CANCER 18/2 :167-178,2018
• Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyJOURNAL OF NEURO-ONCOLOGY 138/3 :667-677,2018
• Treatment outcomes of radiotherapy for anaplastic thyroid cancerRadiation Oncology Journal 36/02 :103-113,2018
• The 18F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomesPLOS ONE 13/9 :e0204918-e0204930,2018
• Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volumeRADIOTHERAPY AND ONCOLOGY 126/1 :139-147,2018
• Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive ChemoradiotherapyFRONTIERS IN ONCOLOGY 8/ :457-466,2018
• Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyJOURNAL OF NEURO-ONCOLOGY 140/2 :445-455,2018
• The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with RadiotherapyJournal of clinical medicine 7/ :512-524,2018
• Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 TrialANNALS OF SURGERY 268/2 :215-222,2018
• High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution studyHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41/1 :146-153,2019
• Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancerSCIENTIFIC REPORTS 9/1 :5,061-,2019
• Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiationRADIATION ONCOLOGY 14/56 :1-8,2019
• A phase II study of intraoperative radiotherapy using a low-energy x-ray source for resectable pancreatic cancer: A study protocolBMC SURGERY 19/1 :31-,2019
• A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patientsBREAST CANCER RESEARCH AND TREATMENT 174/1 :157-163,2019
• Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningiomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 145/5 :1,351-1,360,2019
• Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer.FRONTIERS IN ONCOLOGY 9/5 :-,2019
• Lung adenocarcinoma invasiveness risk in pure ground-glass opacity lung nodules smaller than 2 cmTHORACIC AND CARDIOVASCULAR SURGEON 67/4 :321-328,2019
• Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular CarcinomaMOLECULES AND CELLS 42/7 :530-545,2019
• Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumesHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41/11 :3,916-3,923,2019
• Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05)CANCER RESEARCH AND TREATMENT 51/4 :1,589-1,599,2019
• Different prognosis of patients with esophageal carcinoma with M1a and regional node involvementDIGESTIVE AND LIVER DISEASE 51/11 :1,610-1,616,2019
• Radiotherapy for initial clinically positive internal mammary nodes in breast cancerRadiation Oncology Journal 37/02 :91-100,2019
• Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With RadiotherapyFRONTIERS IN ONCOLOGY 9/1075 :1-10,2019
• Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving TreatmentANNALS OF SURGICAL ONCOLOGY 26/13 :4,294-4,301,2019
[저서]
1. 실용적 부인종양학
2. 군자출판사
• Seong J, Lee IJ, Shim SJ, et al. A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea. Liver Int 2009;29:147-152.
• Lee IJ, Seong J, Shim SJ, et al. Radiotherapeutic parameters predictive of liver complications induced by liver tumor radiotherapy. Int J Radiat Oncol Biol Phys 2009;73:154-158.
• Song T, Suh CO, Lee I, et al. The effect of respiratory motion on forward intensity modulated radiotherapy for breast cancer. Technol Cancer Res Treat 2008;7:207-215.
• Lee IJ, Seong J, Lee CG, et al. Early Clinical Experience and Outcome of Helical Tomotherapy for Multiple Metastatic Lesions. Int J Radiat Oncol Biol Phys 2008 (Article in press).
• 유세환, 성진실, 이익재, et al. 간종양 방사선치료 시 토모테라피 메가볼트 CT를 이용한 치료 여백 평가. 대한방사선종양학회지 2008;26:280-288.
• 안승권, 김용배, 이익재, et al. 사지에 발병한 카포시육종의 방사선치료를 위한 물볼루스 기구의 유용성 고찰. 대한방사선종양학회지 2008;26:189-194.
• Shim SJ, Seong J, Lee IJ, et al. Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinoma. Hepatol Res 2007;37:906-913.
• Seong J, Shim SJ, Lee IJ, et al. Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapy. Int J Radiat Oncol Biol Phys 2007;67:1037-1042.
• 김주영, 이익재, 금기창, et al. Internal Mammary Lymph Node Irradiation after Breast Conservation Surgery: Radiation Pneumonitis versus Dose-Volume Histogram Parameters. 대한방사선종양학회지 2007;25:261-267.
• 금기창, 심수정, 이익재, et al. 1998,1999년도 우리나라에서 시행된 근치적 유방 전절제술 후 방사선치료 현황 조사. 대한방사선종양학회지 2007;25:7-15.
• 이익재, 성진실, 심수정, et al. 간세포암종의 방사선치료 시 발생하는 간독성에 대한 위험인자의 재고찰. 대한간학회지 2006;12:420-428.
• 이익재, 성진실, 심수정, et al. 3차원입체조형방사선치료 계획 시 간종괴의 위치에 따른 최적 조사방향의 결정. 방사선방어학회지 2006;31:187-195.
• 조재호, 김현창, 서창옥, et al. 처방선량 및 치료기법별 치료성적 분석 결과에 기반한 자궁경부암 환자의 최적 방사선치료 스케줄. 대한방사선종양학회지 2005;23:143-156.
• Shin HS, Seong J, Kim WC, et al. Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts. Int J Radiat Oncol Biol Phys 2003;57:105-112.
• 이용하, 박경란, 이종영, et al. 측정기에 따른 고에너지 X-선의 표면 선량 및 최대 선량 지점 고찰. 대한방사선종양학회지 2003;21:322-329.
• Lee IJ, Park KR, Lee KK, et al. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2002;54:768-779.
• Results of definitive radiation therapy in adenosquamous cell carcinoma of the uterine cervix대한암학회지 33/1 :21-26,2001
• 병기 IB 자궁경부암에서 혈관내피세포성장인자(VEGF)의 발현이 예후에 미치는 영향대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 19/4 :335-344,2001
• Prognostic value of vascular endothelial growth factor in stage IB carcinoma of the uterine cervixINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 54/3 :768-779,2002
• 직장암의 근치적 절제술 후 보조 화학요법과 보조 화학방사선 병용요법대한방사선종양학회지(journalofthekoreansocietyfortherapeuticradiologyandoncology) 20/4 :334-342,2002
• Combination of external-beam irradiation and high-dose-rate brachytherapy for inoperable carcinoma of the extra-hepatic bile ductsINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 57/1 :105-112,2003
• Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ductsINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 57/1 :105-112,2003
• 측정기에 따른 고에너지 X-선의 표면 선량 및 최대 선량 지점 고찰대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 21/4 :322-329,2003
• 처방선량 및 치료기법별 치료성적 분석 결과에 기반한 자궁경부암 환자의 최적 방사선치료 스케쥴대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 23/3 :143-156,2005
• 담도암의 방사선치료대한췌담도연구회 1/ :72-79,2005
• 간세포암종의 방사선치료 시 발생하는 간독성에 대한 위험인자의 재고찰The Korean Journal of Hepatology(대한간학회지) 12/3 :420-428,2006
• 3차원입체조형방사선치료 계획 시 간종괴의 위치에 따른 최적 조사 방향의 결정대한방사선방어학회지 31/4 :187-195,2006
• Evaluation of the prognostic value of Okuda, Cancer of the Liver Italian Program, and Japan Integrated Staging systems for hepatocellular carcinoma patients undergoing radiotherapyINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 67/4 :1037-1042,2007
• Radiation-induced hepatic toxicity after radiotherapy combined with chemotherapy for hepatocellular carcinomaHEPATOLOGY RESEARCH 37/ :906-913,2007
• Internal Mammary Lymph Node Irradiation after Breast Conservation Surgery: Radiation Pneumonitis versus Dose-Volume Histogram Parameters대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 25/4 :261-267,2007
• 1998, 1999년도 우리나라에서 시행된 근치적 유방 전절제술 후 방사선치료 현황 조사대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 25/1 :7-15,2007
• The effect of respiratory motion on forward intensity modulated radiotherapy for breast cancerTechnology In Cancer Research & Treatment 7/ :207-215,2008
• 사지에 발병한 카포시육종의 방사선치료를 위한 물볼루스 기구의 유용성 고찰대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 26/3 :189-194,2008
• Treatment Margin Assessment using Mega-Voltage Computed Tomography of a Tomotherapy Unit in the Radiotherapy of a Liver Tumor대한방사선종양학회지(Journal Of The Korean Society For Therapeutic Radiology And Oncology) 26/4 :280-288,2008
• A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in KoreaLiver International 29/ :147-152,2009
• RADIOTHERAPEUTIC PARAMETERS PREDICTIVE OF LIVER COMPLICATIONS INDUCED BY LIVER TUMOR RADIOTHERAPYINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73/1 :154-158,2009
• EARLY CLINICAL EXPERIENCE AND OUTCOME OF HELICAL TOMOTHERAPY FOR MULTIPLE METASTATIC LESIONSINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 73/ :1517-1524,2009
• A Comparison of Treatment Plans using Linac-Based Intensity-Modulated Radiation Therapy and Helical Tomotherapy for Maxillary Sinus CarcinomaTechnology In Cancer Research & Treatment 8/4 :257-263,2009
• 비소세포성 폐암으로 수술 후 방사선치료가 시행된 N2병기 환자들에서 다발 부위 종격동 림프절 전이 여부에 따른 N2병기 구분의 임상적 의미Journal Of The Korean Society For Therapeutic Radiology And Oncology(대한방사선종양학회지) 27/3 :126-132,2009
• TUMOR HETEROGENEITY OF FIGO STAGE III CARCINOMA OF THE UTERINE CERVIXINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75/5 :1323-1328,2009
• Validation of Radiation Volume by Analysis of Recurrence Pattern in Breast-conserving Treatment for Early Breast CancerJournal Of Breast Cancer (한국유방암학회지) 12/4 :257-264,2009
• RISK FACTORS AND DOSE-EFFECT RELATIONSHIP FOR MANDIBULAR OSTEORADIONECROSIS IN ORAL AND OROPHARYNGEAL CANCER PATIENTSINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 75/4 :1084-1091,2009
• 신경회로망을 이용한 4차원 방사선치료에서의 조사 표적 움직임 예측의학물리 20/3 :132-138,2009
• Positional Reproducibility and Effects of a Rectal Balloon in Prostate Cancer RadiotherapyJournal Of Korean Medical Science 24/5 :894-903,2009
• A phase I study of nimotuzumab in combination with radiotherapy in stages IIB-IV non-small cell lung cancer unsuitable for radical therapy: Korean resultsLUNG CANCER 71/1 :55-59,2011
• Selection of the Optimal Radiotherapy Technique for Locally Advanced Hepatocellular CarcinomaJAPANESE JOURNAL OF CLINICAL ONCOLOGY 41/7 :882-889,2011
• Radiosensitizers in Hepatocellular CarcinomaSEMINARS IN RADIATION ONCOLOGY 21/4 :303-311,2011
• Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized StudyCancer Research and Treatment 43/1 :24-31,2011
• Radiotherapeutic Strategies in the Management of Hepatocellular CarcinomaONCOLOGY 81/Suppl :123-133,2011
• Helical tomotherapy for spine oligometastases from gastrointestinal malignancies대한방사선종양학회지 29/4 :219-227,2011
• Effect of Oral Supplementation with Branched-chain Amino Acid during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized StudyCancer Research and Treatment 43/1 :24-31,2011
• USEFULNESS OF POSITRON EMISSION TOMOGRAPHY WITH FLUORINE-18-FLUORODEOXYGLUCOSE IN PREDICTING TREATMENT RESPONSE IN UNRESECTABLE HEPATOCELLULAR CARCINOMA PATIENTS TREATED WITH EXTERNAL BEAM RADIOTHERAPYINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 82/3 :1172-1178,2012
• Is There a Clinical Benefit to Adaptive Planning During Tomotherapy in Patients with Head and Neck Cancer at Risk for Xerostomia?AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 35/3 :261-266,2012
• The significance of ICG-R15 in predicting hepatic toxicity in patients receiving radiotherapy for hepatocellular carcinomaLIVER INTERNATIONAL 32/7 :1165-1171,2012
• The Optimal Selection of Radiotherapy Treatment for Hepatocellular CarcinomaGUT AND LIVER 6/2 :139-148,2012
• Molecular Markers Predict Distant Metastases After Adjuvant Chemoradiation for Rectal CancerINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 84/5 :e577-e584,2012
• Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptorsCELLULAR IMMUNOLOGY 278/1-2 :76-83,2012
• Long-term Survival Outcomes Following Internal Mammary Node Irradiation in Stage II-III Breast Cancer: Results of a Large Retrospective Study With 12-Year Follow-upINTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 86/5 :867-872,2013
• Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular CarcinomaYONSEI MEDICAL JOURNAL 54/5 :1178-1185,2013
• A Comparative Planning Study of Step-and-shoot IMRT versus Helical Tomotherapy in a Model PatientJOURNAL OF THE KOREAN PHYSICAL SOCIETY 63/7 :1481-1485,2013
• Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinomaJOURNAL OF RADIATION RESEARCH 54/6 :1069-1077,2013
• The deep inspiration breath hold technique using Abches reduces cardiac dose in patients undergoing left-sided breast irradiationRadiation oncology journal 31/4 :217-224,2013
• High-dose Versus Standard-dose Radiotherapy with Concurrent Chemotherapy in Stages II-III Esophageal CancerJAPANESE JOURNAL OF CLINICAL ONCOLOGY 44/6 :534-540,2014
• Improved oncologic outcomes with image-guided intensity-modulated radiation therapy using helical tomotherapy in locally advanced hepatocellular carcinomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 140/9 :1595-1605,2014
• Dose escalation using helical tomotherapy improves local control in spine metastases fromprimary hepatic malignanciesLIVER INTERNATIONAL 34/3 :462-468,2014
• Inhibition of IL-17A Suppresses Enhanced-Tumor Growth in Low Dose Pre-Irradiated Tumor BedsPLOS ONE 9/Issue 9 :e106423-,2014
• Postoperative radiotherapy dose correlates with locoregional control in patients with locoregional control in patients with extra-hepatic bile duct cancerRadiation Oncology Journal 32/1 :7-13,2014
• Concurrent Chemoradiotherapy Shows Long-Term Survival after Conversion from Locally Advanced to Resectable Hepatocellular CarcinomaYONSEI MEDICAL JOURNAL 55/6 :1489-1497,2014
• Local control may be the key in improving treatment outcomes of esophageal squamous cell carcinoma undergoing concurrent chemoradiationDIGESTION 90/4 :254-260,2014
• Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patientsRadiation Oncology Journal 33/2 :75-82,2015
• A Feasibility Study of a Tilted Head Position in Helical Tomotherapy for Fractionated Stereotactic Radiotherapy of Intracranial MalignanciesTECHNOLOGY IN CANCER RESEARCH & TREATMENT 14/4 :475-482,2015
• Risk of radiation-induced pneumonitis after helical and static-port tomotherapy in lung cancer patients and experimental ratsRADIATION ONCOLOGY 10/1 :195-,2015
• Clinical Benefit of Hepatic Arterial Infusion Concurrent Chemoradiotherapy in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching AnalysisCANCER RESEARCH AND TREATMENT 48/1 :190-197,2016
• Mechanical quality assurance using light field for linear accelerators with camera calibrationPHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS 32/ :398-402,2016
• Altered Biological Potential and Radioresponse of Murine Tumors in Different MicroenvironmentsCANCER RESEARCH AND TREATMENT 48/2 :727-737,2016
• Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 PatientsCANCER RESEARCH AND TREATMENT 48/2 :583-595,2016
• The Largest Known Survival Analysis of Patients with Brain Metastasis from Thyroid Cancer Based on Prognostic GroupsPLOS ONE 11/4 :e0154739-,2016
• Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinomaONCOTARGET 7/26 :40756-40766,2016
• High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinomaONCOTARGET 7/33 :53921-53929,2016
• Radiological-pathological correlation study of hepatocellular carcinoma undergoing local chemoradiotherapy and surgeryJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 31/9 :1,619-1,627,2016
• Interobserver variability in gross tumor volume delineation for hepatocellular carcinomaSTRAHLENTHERAPIE UND ONKOLOGIE 192/ :714-721,2016
• Optimal Adjuvant Treatment for Curatively Resected Thoracic Esophageal Squamous Cell Carcinoma: A Radiotherapy PerspectiveCANCER RESEARCH AND TREATMENT 49/1 :168-177,2017
• Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volumeRADIOTHERAPY AND ONCOLOGY 122/1 :24-29,2017
• Clinical application of 3D-printed-step-bolus in post-totalmastectomy electron conformal therapyONCOTARGET 8/15 :25,660-26,558,2017
• In vivo dosimetry and acute toxicity in breast cancer patients undergoing intraoperative radiotherapy as boostRadiation Oncology Journal 35/02 :121-128,2017
• Factors affecting survival after concurrent chemoradiation therapy for advanced hepatocellular carcinoma: a retrospective studyRADIATION ONCOLOGY 12/133 :1-8,2017
• Meeting Highlights: The Second Consensus Conference for Breast Cancer Treatment in KoreaJOURNAL OF BREAST CANCER 20/3 :228-233,2017
• Maximum surgical resection and adjuvant intensity-modulated radiotherapy with simultaneous integrated boost for skull base chordomaACTA NEUROCHIRURGICA 159/ :1825-1834,2017
• Dose de-escalation to the normal larynx using conformal radiotherapy reduces toxicity while maintaining oncologic outcome for T1/T2 glottic cancerSCIENTIFIC REPORTS 7/ :15732-,2017
• Indicators and Qualitative Assessment of Lung Cancer Management by Health Insurance Review and Assessment Service (HIRA) of Korea in 2015Tuberculosis and Respiratory Diseases 81/1 :19-28,2018
• Predictors of post-treatment stenosis in cervical esophageal cancer undergoing high-dose radiotherapyWORLD JOURNAL OF GASTROENTEROLOGY 24/7 :862-869,2018
• Locoregional Treatment of the Primary Tumor in Patients With De Novo Stage IV Breast Cancer: A Radiation Oncologist's PerspectiveCLINICAL BREAST CANCER 18/2 :167-178,2018
• Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyJOURNAL OF NEURO-ONCOLOGY 138/3 :667-677,2018
• Treatment outcomes of radiotherapy for anaplastic thyroid cancerRadiation Oncology Journal 36/02 :103-113,2018
• The 18F-FDG PET/CT response to radiotherapy for patients with spinal metastasis correlated with the clinical outcomesPLOS ONE 13/9 :e0204918-e0204930,2018
• Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volumeRADIOTHERAPY AND ONCOLOGY 126/1 :139-147,2018
• Prognostic Significance of Sarcopenia With Inflammation in Patients With Head and Neck Cancer Who Underwent Definitive ChemoradiotherapyFRONTIERS IN ONCOLOGY 8/ :457-466,2018
• Impact of adjuvant treatments on survival in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup studyJOURNAL OF NEURO-ONCOLOGY 140/2 :445-455,2018
• The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with RadiotherapyJournal of clinical medicine 7/ :512-524,2018
• Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 TrialANNALS OF SURGERY 268/2 :215-222,2018
• High-dose versus standard-dose radiation therapy for cervical esophageal cancer: Retrospective single-institution studyHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41/1 :146-153,2019
• Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancerSCIENTIFIC REPORTS 9/1 :5,061-,2019
• Evaluation of optimal treatment planning for radiotherapy of synchronous bilateral breast cancer including regional lymph node irradiationRADIATION ONCOLOGY 14/56 :1-8,2019
• A phase II study of intraoperative radiotherapy using a low-energy x-ray source for resectable pancreatic cancer: A study protocolBMC SURGERY 19/1 :31-,2019
• A phase II study investigating the acute toxicity of targeted intraoperative radiotherapy as tumor-bed boost plus whole breast irradiation after breast-conserving surgery in Korean patientsBREAST CANCER RESEARCH AND TREATMENT 174/1 :157-163,2019
• Risk group-adapted adjuvant radiotherapy for WHO grade I and II skull base meningiomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 145/5 :1,351-1,360,2019
• Relationship Between Sarcopenia and Prognosis in Patient With Concurrent Chemo-Radiation Therapy for Esophageal Cancer.FRONTIERS IN ONCOLOGY 9/5 :-,2019
• Lung adenocarcinoma invasiveness risk in pure ground-glass opacity lung nodules smaller than 2 cmTHORACIC AND CARDIOVASCULAR SURGEON 67/4 :321-328,2019
• Radiation-Induced CXCL12 Upregulation via Histone Modification at the Promoter in the Tumor Microenvironment of Hepatocellular CarcinomaMOLECULES AND CELLS 42/7 :530-545,2019
• Patterns of local recurrence after curative resection and reconstruction for oropharyngeal and oral cancers: Implications for postoperative radiotherapy target volumesHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41/11 :3,916-3,923,2019
• Treatment Outcome after Fractionated Conformal Radiotherapy for Hepatocellular Carcinoma in Patients with Child-Pugh Classification B in Korea (KROG 16-05)CANCER RESEARCH AND TREATMENT 51/4 :1,589-1,599,2019
• Different prognosis of patients with esophageal carcinoma with M1a and regional node involvementDIGESTIVE AND LIVER DISEASE 51/11 :1,610-1,616,2019
• Radiotherapy for initial clinically positive internal mammary nodes in breast cancerRadiation Oncology Journal 37/02 :91-100,2019
• Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With RadiotherapyFRONTIERS IN ONCOLOGY 9/1075 :1-10,2019
• Redefining Eligibility by Analyzing Canceled Intraoperative Radiotherapy as a Boost for Patients Undergoing Breast-Conserving TreatmentANNALS OF SURGICAL ONCOLOGY 26/13 :4,294-4,301,2019
[저서]
1. 실용적 부인종양학
2. 군자출판사